Glycidyltrimethylammonium chloride

Catalog No. :
ACAPQF295
CAS No. :
3033-77-0
Molecular Formula :
C6H14ClNO
Molecular Weight :
151.64

IUPAC Name:N,N,N-trimethyl-1-(oxiran-2-yl)methanaminium chloride

Glycidyltrimethylammonium chloride structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
No pack options available.

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product NameGlycidyltrimethylammonium chloride
IUPAC NameN,N,N-trimethyl-1-(oxiran-2-yl)methanaminium chloride
MDL No.MFCD00011940
Molecular FormulaC6H14ClNO
Molecular Weight151.64
SMILESC[N+](C)(CC1CO1)C.[Cl-]
InChI KeyPUVAFTRIIUSGLK-UHFFFAOYSA-M
SynonymCAS-3033-77-0 | Trimethyl[(oxiran-2-yl)methyl]azanium chloride | EINECS 221-221-0 | glycidyltrimethylammoniumchloride | Oxiranemethanaminium,N,N-trimethyl-, chloride | Tox21_300176 | EN300-244014 | 283XH39M8X | Ammonium, (2,3-epoxypropyl)trimethyl-, chlor
CAS No.3033-77-0
PubChem CID18205

Safety Data

Pictogram
CorrosiveHarmful or irritantHealth hazard
Signal Word
Gefahr
Hazard Statement(s)
H332-H317-H318-H341-H350-H360-H371-H373-H412
Precautionary Statement(s)
P201-P202-P260-P264-P270-P271-P272-P273-P280-P301+P312+P330-P302+P352+P312-P304+P340+P312-P305+P351+P338+P310-P308+P311-P333+P313-P405-P501

Synthetic Route by SureRoute

1. ACAPQF295 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACMQPV478 route compound structure diagram
    ACMQPV4783004-51-1 In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACAPQF295 route product structure diagram
    ACAPQF2953033-77-0
Inquiry

2. ACAPQF295 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACAPQF295 route product structure diagram
    ACAPQF2953033-77-0
Inquiry

Comments (0)